A systematic review to assess the ‘ treat-and-extend ’ dosing regimen for neovascular age-related macular degeneration using ranibizumab

A systematic review to assess the ‘treat-and-extend’ dosing regimen for neovascular age-related macular degeneration using ranibizumab Eye advance online publication, May 5 2017. doi:10.1038/eye.2017.67 Authors: S R Rufai, H Almuhtaseb, R M Paul, B L Stuart, T Kendrick, H Lee & A J Lotery

http://dx.doi.org/10.1038/eye.2017.67

Source: Eye - May 5, 2017 Category: Opthalmology Authors: S R Rufai H Almuhtaseb R M Paul B L Stuart T Kendrick H Lee A J Lotery Source Type: research

More News: Age-Related Macular Degeneration (AMD) | Lucentis | Ranibizumab Injection